Plasma Fractionation Market Analysis Through 2030: Market Size, Growth Trends And Industry Outlook
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Plasma Fractionation Market Growth Potential: How Will Market Size Shift Through 2030?#_x000D_
The plasma fractionation market size has seen rapid growth in recent years. It is anticipated to expand from $34.14 billion in 2025 to $37.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.2%. Historically, this market’s growth can be attributed to several factors, including increased demand for immunoglobulins, a rise in the prevalence of hematological disorders, advancements in plasma fractionation technology, the expansion of hospital and clinical infrastructure, and a greater awareness of plasma-derived therapies._x000D_
_x000D_
The plasma fractionation market is projected to undergo significant expansion in the coming years, reaching $55.85 billion by 2030, with a compound annual growth rate (CAGR) of 10.4%. This anticipated growth is fueled by factors such as the increasing adoption of precision medicine, the integration of artificial intelligence in plasma manufacturing, the expansion of global biopharmaceutical collaborations, rising investments in plasma collection centers, and the development of novel plasma-derived therapies. Prominent trends expected during this forecast period include advanced plasma fractionation techniques, the diversification of biopharmaceutical products, enhanced quality control and regulatory compliance, the growth of contract manufacturing organizations (CMOs/CDMOs), and optimized supply chain management for plasma products._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Plasma Fractionation Market Growth Backed By Core Demand Fundamentals#_x000D_
A rising prevalence of chronic illnesses is anticipated to drive expansion in the plasma fractionation market moving ahead. These long-term conditions, requiring continuous medical management for a year or longer, encompass ailments like heart disease, cancer, and diabetes. Providing plasma products for chronic disease patients helps reduce illness, enhances life quality, and offers cost-effective solutions, consequently boosting the need for plasma fractionation. An example of this trend is seen in March 2025, where GOV.UK, a UK-based non-profit government organization, reported that GP noted a type 2 diabetes prevalence of 7.0% among adults aged 17 and over in England in March 2024, marking a rise from 6.8% in March 2023. Hence, a growing incidence of chronic diseases across all age groups is projected to stimulate the growth of the plasma fractionation market._x000D_
_x000D_
#Plasma Fractionation Market Segment Trends And Revenue Contributors#_x000D_
The plasma fractionation market covered in this report is segmented – _x000D_
_x000D_
1) By Product: Immunoglobulins, Coagulation Factors, Albumin, Protease Inhibitors _x000D_
2) By Application: Immunology, Hematology, Neurology, Critical Care, Hemato-Oncology, Rheumatology_x000D_
3) By End User: Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes_x000D_
_x000D_
Subsegments:_x000D_
1) By Immunoglobulins: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG) _x000D_
2) By Coagulation Factors: Factor VIII, Factor IX, Prothrombin Complex Concentrates (PCC) _x000D_
3) By Albumin: Human Albumin, Bovine Serum Albumin (BSA) _x000D_
4) By Protease Inhibitors: Alpha-1 Antitrypsin (AAT), C1 Esterase Inhibitor (C1-INH) _x000D_
_x000D_
#Plasma Fractionation Market Growth Trends Reshaping The Competitive Landscape#_x000D_
Major companies within the market are implementing novel technologies, including high-tech facility processes that transform donated human plasma into vital medicines and leverage advanced technology to make the procedure more streamlined and secure. For example, in March 2023, CSL Behring, a German-based company, inaugurated a new $470 million plasma fractionation facility employing cutting-edge technology to enhance the efficiency and safety of plasma processing, leading to higher quality and more dependable medicines. By increasing the provision of these critical medicines, the facility contributes to meeting the escalating demand, ensuring more patients can access life-saving treatments. Its advanced automation and self-cleaning systems significantly lower the risk of contamination and improve overall hygienic conditions, thereby enhancing patient safety._x000D_
_x000D_
#Plasma Fractionation Market Competitive Landscape: Which Companies Lead The Industry?#_x000D_
Major companies operating in the plasma fractionation market are Baxter International Inc., Bio Products Laboratory Limited, Biotest AG, CSL Limited, Grifols S. A, ADMA Biologics Inc., Green Cross Corporation, Hualan Bioengineering Inc., Intas Pharmaceuticals Ltd., Japan Blood Products Organization, Kedrion S. P. A., Kamada Ltd., LFB Biomedicaments S. A. S, Octapharma AG, Sanquin Plasma Products B. V., Shanghai Raas Blood Products Co. Ltd., Takeda Pharmaceutical Company, Terumo BCT, China Biologic Products Holdings Inc., China National Biotec Group, Emergent BioSolutions Inc., Bharat Serum Vaccines Limited, Plasma Therapeutics, Prothya Biosolutions B. V., BioPharma Plasma LLC, BioLife Plasma Services LP _x000D_
_x000D_
#View The Full Plasma Fractionation Market Report:#_x000D_
_x000D_
#Plasma Fractionation Market Global Footprint: Which Region Leads The Market?#_x000D_
North America was the largest region in the plasma fractionation market in 2025.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
